Circulating CD8+ T cells in oral or head and neck cancer patients have been well-characterized for their susceptibility to apoptosis and the responsible Fas/FasL or TRAIL/TRAILR signaling pathway [15]–[16]. The gene discussed is CD8A; the disease is head and neck cancer.